{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:47:19Z","timestamp":1791863239552,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20K08938"],"award-info":[{"award-number":["JP20K08938"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K08035"],"award-info":[{"award-number":["JP23K08035"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.neo.2026.101370","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:10:19Z","timestamp":1790122219000},"page":"101370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Glucose-containing carriers in cancer therapy (GLUCOSE-ONC): A multistream critical review and quantitative exposure framework"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0460-9599","authenticated-orcid":false,"given":"Shinichiro","family":"Kashiwagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chika","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Asaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeko","family":"Henmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanae","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0901-9482","authenticated-orcid":false,"given":"Huixian","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Kikukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Gose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Nishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuka","family":"Kochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukie","family":"Tauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Ogisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsune","family":"Shibutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7489-0282","authenticated-orcid":false,"given":"Hisakazu","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamami","family":"Morisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhito","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2026.101370_bib0001","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.neo.2026.101370_bib0002","unstructured":"Sanofi. ELOXATIN (oxaliplatin) prescribing information. Available at: https:\/\/products.sanofi.us\/eloxatin\/eloxatin.html. Accessed 28 August 2026."},{"key":"10.1016\/j.neo.2026.101370_bib0003","unstructured":"DailyMed. ENHERTU (fam-trastuzumab deruxtecan-nxki) prescribing information. Available at: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=7e67e73e-ddf4-4e4d-8b50-09d7514910b6. Accessed 28 August 2026."},{"key":"10.1016\/j.neo.2026.101370_bib0004","unstructured":"DailyMed. DATROWAY (datopotamab deruxtecan-dlnk) prescribing information. Available at: https:\/\/dailymed.nlm.nih.gov\/dailymed\/fda\/fdaDrugXsl.cfm?setid=2950227c-6230-4ca4-a135-46e44d9424a0&type=display. Accessed 28 August 2026."},{"key":"10.1016\/j.neo.2026.101370_bib0005","unstructured":"Pfizer. CAMPTOSAR (irinotecan hydrochloride) prescribing information. Available at: https:\/\/labeling.pfizer.com\/showlabeling.aspx?id=533. Accessed 28 August 2026."},{"key":"10.1016\/j.neo.2026.101370_bib0006","unstructured":"Sanofi. TAXOTERE (docetaxel) prescribing information. Available at: https:\/\/products.sanofi.us\/Taxotere_1Vial\/Taxotere.html. Accessed 28 August 2026."},{"key":"10.1016\/j.neo.2026.101370_bib0007","unstructured":"US Food and Drug Administration. HERCEPTIN (trastuzumab) prescribing information. Revised July 2026. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2026\/103792s5359lbl.pdf. Accessed 28 August 2026."},{"key":"10.1016\/j.neo.2026.101370_bib0008","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.neo.2026.101370_bib0009","doi-asserted-by":"crossref","first-page":"l6890","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.neo.2026.101370_bib0010","doi-asserted-by":"crossref","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst. Rev."},{"key":"10.1016\/j.neo.2026.101370_bib0011","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.neo.2026.101370_bib0012","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00001648-199901000-00008","article-title":"Causal diagrams for epidemiologic research","volume":"10","author":"Greenland","year":"1999","journal-title":"Epidemiology"},{"key":"10.1016\/j.neo.2026.101370_bib0013","first-page":"3271","article-title":"Use of glucose solution for the alleviation of gemcitabine-induced vascular pain: a double-blind randomized crossover study","volume":"21","author":"Nagai","year":"2013","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.neo.2026.101370_bib0014","first-page":"97","article-title":"Reduction of 5-fluorouracil toxicity in man with retention of anticancer effects by prolonged intravenous administration in 5 per cent dextrose","volume":"8","author":"Lemon","year":"1960","journal-title":"Cancer Chemother Rep."},{"key":"10.1016\/j.neo.2026.101370_bib0015","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1227\/00006123-198704000-00012","article-title":"Intracarotid chemotherapy with 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in 5% dextrose in water in the treatment of malignant glioma","volume":"20","author":"Johnson","year":"1987","journal-title":"Neurosurgery"},{"key":"10.1016\/j.neo.2026.101370_bib0016","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1245\/s10434-020-08330-y","article-title":"Dextrose-containing carrier solution for hyperthermic intraperitoneal chemotherapy: increased intraoperative hyperglycemia and postoperative complications","volume":"27","author":"Torphy","year":"2020","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.neo.2026.101370_bib0017","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jss.2020.06.055","article-title":"Impact of perfusate glucose concentration on perioperative outcomes in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"256","author":"Lindsey","year":"2020","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.neo.2026.101370_bib0019","first-page":"233","article-title":"Parenteral nutrition in cancer patients undergoing chemotherapy: a meta-analysis","volume":"6","author":"McGeer","year":"1990","journal-title":"Nutrition"},{"key":"10.1016\/j.neo.2026.101370_bib0023","first-page":"421","article-title":"Effect of total parenteral nutrition on survival in advanced colon cancer","volume":"4","author":"Nixon","year":"1981","journal-title":"Cancer Detect. Prev."},{"issue":"Suppl 5","key":"10.1016\/j.neo.2026.101370_bib0024","first-page":"121","article-title":"Total parenteral nutrition as an adjunct to chemotherapy of metastatic colorectal cancer","volume":"65","author":"Nixon","year":"1981","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.neo.2026.101370_bib0026","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/iju.13228","article-title":"Oncological and functional outcomes of postoperative total parenteral nutrition after radical cystectomy in bladder cancer patients: a single-center randomized trial","volume":"23","author":"Vidal","year":"2016","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.neo.2026.101370_bib0028","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10549-025-07745-z","article-title":"Continuous glucose monitoring to characterize hyperglycemia during chemotherapy for early stage breast cancer","volume":"212","author":"Ulene","year":"2025","journal-title":"Breast. Cancer Res. Treat."},{"key":"10.1016\/j.neo.2026.101370_bib0018","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1245\/s10434-017-6284-6","article-title":"Implications of hyperthermic intraperitoneal chemotherapy perfusion-related hyperglycemia","volume":"25","author":"Stewart","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.neo.2026.101370_bib0020","first-page":"1","article-title":"A prospective, randomized study of adjuvant parenteral nutrition in the treatment of sarcomas: results of metabolic and survival studies","volume":"96","author":"Shamberger","year":"1984","journal-title":"Surgery"},{"key":"10.1016\/j.neo.2026.101370_bib0021","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/978-3-642-81685-7_39","article-title":"Follow-up of a randomized trial for oat cell carcinoma evaluating the efficacy of peripheral intravenous nutrition as adjunct treatment","volume":"80","author":"Serrou","year":"1982","journal-title":"Recent. Results. Cancer Res."},{"key":"10.1016\/j.neo.2026.101370_bib0022","first-page":"195","article-title":"A prospective randomized study of adjuvant parenteral nutrition in the treatment of advanced diffuse lymphoma: influence on survival","volume":"90","author":"Popp","year":"1981","journal-title":"Surgery"},{"key":"10.1016\/j.neo.2026.101370_bib0025","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1089\/jpm.2014.0082","article-title":"A randomized phase II study to assess the effectiveness of fluid therapy or intensive nutritional support on survival in patients with advanced cancer who cannot be nourished via the enteral route","volume":"17","author":"Oh","year":"2014","journal-title":"J. Palliat. Med."},{"key":"10.1016\/j.neo.2026.101370_bib0027","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/01635581.2020.1784441","article-title":"Home parenteral nutrition in patients with advanced cancer: a systematic review and meta-analysis","volume":"73","author":"O\u2019Hanlon","year":"2021","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.neo.2026.101370_bib0029","doi-asserted-by":"crossref","DOI":"10.1177\/1758835919866964","article-title":"High blood sugar levels but not diabetes mellitus significantly enhance oxaliplatin chemoresistance in patients with stage III colorectal cancer receiving adjuvant FOLFOX6 chemotherapy","volume":"11","author":"Yang","year":"2019","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.neo.2026.101370_bib0030","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1038\/s41467-023-38921-8","article-title":"Increased glucose availability sensitizes pancreatic cancer to chemotherapy","volume":"14","author":"Vaziri-Gohar","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2026.101370_bib0031","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12038-020-00065-y","article-title":"Sensitization of hepatocellular carcinoma cells towards doxorubicin and sorafenib is facilitated by glucose-dependent alterations in reactive oxygen species, P-glycoprotein and DKK4","volume":"45","author":"Chouhan","year":"2020","journal-title":"J. Biosci."},{"key":"10.1016\/j.neo.2026.101370_bib0032","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1159\/000525977","article-title":"Glucose conferred irinotecan chemoresistance through divergent actions of pyruvate and ATP in cell death and proliferation of colorectal cancer","volume":"100","author":"Huang","year":"2022","journal-title":"Oncology"},{"key":"10.1016\/j.neo.2026.101370_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272449","article-title":"Glucose deprivation reduces proliferation and motility, and enhances the antiproliferative effects of paclitaxel and doxorubicin in breast cell lines in vitro","volume":"17","author":"Khajah","year":"2022","journal-title":"PLoS. One"},{"key":"10.1016\/j.neo.2026.101370_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.151887","article-title":"Glucose deprivation induces cisplatin resistance through upregulation of SLC7A11 (xCT) expression in endometrial cancer cells","volume":"766","author":"Aoyama","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neo.2026.101370_bib0035","doi-asserted-by":"crossref","first-page":"e370","DOI":"10.1097\/CAD.0000000000001215","article-title":"Glucose deprivation enhances resistance to paclitaxel via ELAVL2\/4-mediated modification of glycolysis in ovarian cancer cells","volume":"33","author":"Park","year":"2022","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.neo.2026.101370_bib0036","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1210\/clinem\/dgad537","article-title":"Endogenous glucose production in patients with glycogen storage disease type ia estimated by oral D-[6,6-\u00b2H\u2082]-glucose","volume":"109","author":"Rossi","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neo.2026.101370_bib0037","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1200\/JCO.2015.63.4238","article-title":"Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study","volume":"33","author":"Andr\u00e9","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neo.2026.101370_bib0038","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(11)61625-5","article-title":"Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials","volume":"379","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.neo.2026.101370_bib0039","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/dme.13770","article-title":"Diurnal profile of interstitial glucose following dexamethasone prophylaxis for chemotherapy treatment of gynaecological cancer","volume":"35","author":"Lyall","year":"2018","journal-title":"Diabet. Med."}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626001028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626001028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:22:14Z","timestamp":1791861734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558626001028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":39,"alternative-id":["S1476558626001028"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2026.101370","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucose-containing carriers in cancer therapy (GLUCOSE-ONC): A multistream critical review and quantitative exposure framework","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2026.101370","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101370"}}